These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3942779)

  • 21. Isolation and characterization of mucin from the serum of cystic fibrosis patients.
    Roberts DD; Rose MC; Wang WT; Chernick MS; Frates RC
    Am J Respir Cell Mol Biol; 1990 Apr; 2(4):373-9. PubMed ID: 2322469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis.
    Mantle M; Forstner GG; Forstner JF
    Biochem J; 1984 Dec; 224(2):345-54. PubMed ID: 6517857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunoglobulins (IgG, secretory-IgA) and function of parotid gland in children with cystic fibrosis, with bronchial asthma, and with chronic bronchitis (author's transl)].
    Hein J; Brock J; David A; Grimm J
    Z Erkr Atmungsorgane; 1978 Jan; 151(3):222-30. PubMed ID: 741822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptides of human bronchial mucus glycoproteins. Size determination by electron microscopy and by biosynthetic experiments.
    Marianne T; Perini JM; Lafitte JJ; Houdret N; Pruvot FR; Lamblin G; Slayter HS; Roussel P
    Biochem J; 1987 Nov; 248(1):189-95. PubMed ID: 2449163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural analysis of purified human tracheobronchial mucins.
    Gupta R; Jentoft N; Jamieson AM; Blackwell J
    Biopolymers; 1990 Feb; 29(2):347-55. PubMed ID: 2331503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals.
    Rose MC; Brown CF; Jacoby JZ; Lynn WS; Kaufman B
    Pediatr Res; 1987 Nov; 22(5):545-51. PubMed ID: 3684381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical characterization of a minor mucin component from cystic fibrosis tracheobronchial secretions.
    Padhye NV; Naziruddin B; Desai VC; Reyes de la Rocha S; Sachdev GP
    Biochim Biophys Acta; 1991 Apr; 1077(3):332-8. PubMed ID: 2029532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of monkey (Macaca nemestrina) tracheobronchial mucin.
    Devaraj H; Griffith JW; Sheykhnazari M; Naziruddin B; Sachdev GP; Bhavanandan VP
    Arch Biochem Biophys; 1993 Apr; 302(1):285-93. PubMed ID: 8470904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of canine tracheobronchial mucin glycoprotein.
    Ringler NJ; Selvakumar R; Woodward HD; Simet IM; Bhavanandan VP; Davidson EA
    Biochemistry; 1987 Aug; 26(17):5322-8. PubMed ID: 3676256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibronectin: source of mannose in a highly purified respiratory mucin.
    Bhattacharyya SN; Kaufman B; Khorrami A; Enriquez JI; Manna B
    Inflammation; 1988 Oct; 12(5):433-46. PubMed ID: 3198249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide mapping reveals differences in the non-glycosylated domains of cystic fibrosis and normal tracheobronchial mucins.
    Desai VC; Shankar V; de la Rocha SR; Sachdev GP
    Indian J Biochem Biophys; 1993 Dec; 30(6):382-8. PubMed ID: 8005622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of delipidation on the major antigenic determinant of purified human intestinal mucin.
    Mantle M; Forstner JF
    Biochem Cell Biol; 1986 Mar; 64(3):223-8. PubMed ID: 2424478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate chains from human bronchial mucus glycoproteins: a wide spectrum of oligosaccharide structures.
    Lamblin G; Lhermitte M; Klein A; Roussel P; Van Halbeek H; Vliegenthart JF
    Biochem Soc Trans; 1984 Aug; 12(4):599-600. PubMed ID: 6489589
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation of bronchial mucins from cystic fibrosis sputum by use of citraconic anhydride.
    Snyder CE; Nadziejko CE; Herp A
    Carbohydr Res; 1982 Jul; 105(1):87-93. PubMed ID: 7116358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchial lability in children suffering from some diseases of the bronchi.
    Haluszka J; Sciślicki A
    Respiration; 1975; 32(3):217-26. PubMed ID: 1118680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions.
    Van-Seuningen I; Houdret N; Hayem A; Davril M
    Int J Biochem; 1992 Feb; 24(2):303-11. PubMed ID: 1733797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macromolecular and lipid constituents of bronchial epithelial mucus.
    Reid LM; Bhaskar KR
    Symp Soc Exp Biol; 1989; 43():201-19. PubMed ID: 2701477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory reaction and airway damage in cystic fibrosis.
    Barton AD; Ryder K; Lourenço RV; Dralle W; Weiss SG
    J Lab Clin Med; 1976 Sep; 88(3):423-6. PubMed ID: 8575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates.
    Scharfman A; Degroote S; Beau J; Lamblin G; Roussel P; Mazurier J
    Glycobiology; 1999 Aug; 9(8):757-64. PubMed ID: 10406841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.